$129.55
2.491.96%
À la fermeture: -
$129.55
0.000.00%
Après les heures de négociation: Oct 24, 4:00 PM EDT
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Axsome Therapeutics Inc (NASDAQ:AXSM) a augmenté lors de la dernière période de déclaration, augmentant de en hausse de 3.38M à 3.44M. Cela représente 8.43% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Axsome Therapeutics Corp (XNAS:AXSM) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 462.39K actions échangées par jour, il faudrait 7.43 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
3.44M
Intérêt à court terme %
8.43%
Jours de couverture
7.43
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
AXSM | Axsome Therapeutics, Inc. Comm | 10/15/2025 | 10/24/2025 | 8.43% | 40,764,474 | 3,437,283 | 462,386 | 7.43 | |
AXSM | Axsome Therapeutics, Inc. Comm | 09/30/2025 | 10/09/2025 | 8.29% | 40,764,474 | 3,380,948 | 473,895 | 7.13 | |
AXSM | Axsome Therapeutics, Inc. Comm | 09/15/2025 | 09/24/2025 | 8.47% | 40,764,474 | 3,451,398 | 614,417 | 5.62 | |
AXSM | Axsome Therapeutics, Inc. Comm | 08/29/2025 | 09/10/2025 | 8.61% | 40,764,474 | 3,509,493 | 576,553 | 6.09 | |
AXSM | Axsome Therapeutics, Inc. Comm | 08/15/2025 | 08/26/2025 | 9.13% | 40,764,474 | 3,720,743 | 564,153 | 6.6 | |
AXSM | Axsome Therapeutics, Inc. Comm | 07/31/2025 | 08/11/2025 | 9.01% | 40,764,474 | 3,673,567 | 639,652 | 5.74 | |
AXSM | Axsome Therapeutics, Inc. Comm | 07/15/2025 | 07/24/2025 | 8.90% | 40,764,474 | 3,629,532 | 600,585 | 6.04 | |
AXSM | Axsome Therapeutics, Inc. Comm | 06/30/2025 | 07/10/2025 | 10.02% | 40,764,474 | 4,083,784 | 743,764 | 5.49 | |
AXSM | Axsome Therapeutics, Inc. Comm | 06/13/2025 | 06/25/2025 | 9.86% | 40,764,474 | 4,018,501 | 677,267 | 5.93 | |
AXSM | Axsome Therapeutics, Inc. Comm | 05/30/2025 | 06/10/2025 | 9.53% | 40,764,474 | 3,883,989 | 497,663 | 7.8 | |
AXSM | Axsome Therapeutics, Inc. Comm | 05/15/2025 | 05/27/2025 | 9.53% | 40,764,474 | 3,886,568 | 688,562 | 5.64 | |
AXSM | Axsome Therapeutics, Inc. Comm | 04/30/2025 | 05/09/2025 | 10.29% | 40,764,474 | 4,195,039 | 606,500 | 6.92 | |
AXSM | Axsome Therapeutics, Inc. Comm | 04/15/2025 | 04/25/2025 | 10.85% | 40,764,474 | 4,421,076 | 1,123,996 | 3.93 | |
AXSM | Axsome Therapeutics, Inc. Comm | 03/31/2025 | 04/09/2025 | 12.63% | 40,764,474 | 5,147,725 | 562,128 | 9.16 | |
AXSM | Axsome Therapeutics, Inc. Comm | 03/14/2025 | 03/25/2025 | 12.03% | 40,764,474 | 4,905,057 | 610,071 | 8.04 | |
AXSM | Axsome Therapeutics, Inc. Comm | 02/28/2025 | 03/11/2025 | 14.01% | 40,764,474 | 5,710,793 | 1,021,353 | 5.59 | |
AXSM | Axsome Therapeutics, Inc. Comm | 02/14/2025 | 02/26/2025 | 14.39% | 40,764,474 | 5,867,051 | 1,288,585 | 4.55 | |
AXSM | Axsome Therapeutics, Inc. Comm | 01/31/2025 | 02/11/2025 | 13.86% | 40,461,447 | 5,607,008 | 959,751 | 5.84 | |
AXSM | Axsome Therapeutics, Inc. Comm | 01/15/2025 | 01/27/2025 | 14.22% | 40,461,447 | 5,752,862 | 998,323 | 5.76 | |
AXSM | Axsome Therapeutics, Inc. Comm | 12/31/2024 | 01/10/2025 | 16.36% | 40,461,447 | 6,619,135 | 878,436 | 7.54 | |
AXSM | Axsome Therapeutics, Inc. Comm | 12/13/2024 | 12/24/2024 | 16.10% | 40,461,447 | 6,516,027 | 442,591 | 14.72 | |
AXSM | Axsome Therapeutics, Inc. Comm | 11/29/2024 | 12/10/2024 | 17.49% | 40,461,447 | 7,075,616 | 498,562 | 14.19 | |
AXSM | Axsome Therapeutics, Inc. Comm | 11/15/2024 | 11/26/2024 | 19.00% | 40,461,447 | 7,687,443 | 674,076 | 11.4 | |
AXSM | Axsome Therapeutics, Inc. Comm | 10/31/2024 | 11/11/2024 | 19.19% | 39,494,898 | 7,577,624 | 365,833 | 20.71 | |
AXSM | Axsome Therapeutics, Inc. Comm | 10/15/2024 | 10/24/2024 | 19.03% | 39,494,898 | 7,515,183 | 448,777 | 16.75 | |
AXSM | Axsome Therapeutics, Inc. Comm | 09/30/2024 | 10/09/2024 | 19.64% | 39,494,898 | 7,758,630 | 382,362 | 20.29 | |
AXSM | Axsome Therapeutics, Inc. Comm | 09/13/2024 | 09/24/2024 | 19.42% | 39,494,898 | 7,671,607 | 528,478 | 14.52 | |
AXSM | Axsome Therapeutics, Inc. Comm | 08/30/2024 | 09/11/2024 | 19.28% | 39,494,898 | 7,614,587 | 337,376 | 22.57 | |
AXSM | Axsome Therapeutics, Inc. Comm | 08/15/2024 | 08/26/2024 | 19.41% | 39,494,898 | 7,665,579 | 506,081 | 15.15 | |
AXSM | Axsome Therapeutics, Inc. Comm | 07/31/2024 | 08/09/2024 | 20.61% | 39,494,898 | 8,141,332 | 514,424 | 15.83 | |
AXSM | Axsome Therapeutics, Inc. Comm | 07/15/2024 | 07/24/2024 | 20.97% | 39,494,898 | 8,282,197 | 676,401 | 12.24 | |
AXSM | Axsome Therapeutics, Inc. Comm | 06/28/2024 | 07/10/2024 | 21.73% | 39,494,898 | 8,580,858 | 912,456 | 9.4 | |
AXSM | Axsome Therapeutics, Inc. Comm | 06/14/2024 | 06/26/2024 | 22.51% | 39,494,898 | 8,892,039 | 921,237 | 9.65 | |
AXSM | Axsome Therapeutics, Inc. Comm | 05/31/2024 | 06/11/2024 | 20.95% | 39,494,898 | 8,273,604 | 511,737 | 16.17 | |
AXSM | Axsome Therapeutics, Inc. Comm | 05/15/2024 | 05/24/2024 | 19.22% | 39,494,898 | 7,591,361 | 629,722 | 12.06 | |
AXSM | Axsome Therapeutics, Inc. Comm | 04/30/2024 | 05/09/2024 | 19.52% | 39,494,898 | 7,710,313 | 542,014 | 14.23 | |
AXSM | Axsome Therapeutics, Inc. Comm | 04/15/2024 | 04/24/2024 | 19.62% | 39,492,391 | 7,748,616 | 540,130 | 14.35 | |
AXSM | Axsome Therapeutics, Inc. Comm | 03/28/2024 | 04/09/2024 | 19.44% | 39,354,874 | 7,650,712 | 738,419 | 10.36 | |
AXSM | Axsome Therapeutics, Inc. Comm | 03/15/2024 | 03/26/2024 | 18.54% | 39,354,874 | 7,297,793 | 1,008,188 | 7.24 | |
AXSM | Axsome Therapeutics, Inc. Comm | 02/29/2024 | 03/11/2024 | 18.98% | 39,354,874 | 7,470,339 | 986,904 | 7.57 | |
AXSM | Axsome Therapeutics, Inc. Comm | 02/15/2024 | 02/27/2024 | 19.10% | 39,354,874 | 7,515,442 | 519,189 | 14.48 | |
AXSM | Axsome Therapeutics, Inc. Comm | 01/31/2024 | 02/09/2024 | 19.07% | 39,300,046 | 7,492,970 | 583,376 | 12.84 | |
AXSM | Axsome Therapeutics, Inc. Comm | 01/12/2024 | 01/24/2024 | 21.17% | 39,300,046 | 8,319,949 | 775,839 | 10.72 | |
AXSM | Axsome Therapeutics, Inc. Comm | 12/29/2023 | 01/10/2024 | 21.44% | 39,300,046 | 8,424,012 | 622,161 | 13.54 | |
AXSM | Axsome Therapeutics, Inc. Comm | 12/15/2023 | 12/27/2023 | 21.26% | 39,300,046 | 8,356,744 | 644,237 | 12.97 | |
AXSM | Axsome Therapeutics, Inc. Comm | 11/30/2023 | 12/11/2023 | 21.50% | 39,300,046 | 8,450,005 | 617,295 | 13.69 | |
AXSM | Axsome Therapeutics, Inc. Comm | 11/15/2023 | 11/27/2023 | 19.45% | 39,300,046 | 7,642,617 | 825,113 | 9.26 | |
AXSM | Axsome Therapeutics, Inc. Comm | 10/31/2023 | 11/09/2023 | 18.69% | 39,300,046 | 7,345,238 | 604,716 | 12.15 |
À la recherche des actions les plus vendues à découvert?